SYS-CON MEDIA Authors: Jayaram Krishnaswamy, Lori MacVittie, Gilad Parann-Nissany, Unitiv Blog, Bob Gourley

News Feed Item

Global Computational Biology Market Report 2013 - 2018

DUBLIN, January 9, 2014 /PRNewswire/ --


Research and Markets (http://www.researchandmarkets.com/research/x7rj4s/computational) has announced the addition of the "Global Computational Biology Market Report 2013 - 2018" report to their offering.
     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The computational biology market deals with the use of biology and computers for drug discovery and drug development. This is conducted through modeling and simulation models for pharmacokinetics and pharmacodynamics. Rise in late stage drug failure coupled with contraction of innovative drugs has led to huge financial losses to the biotech pharmaceutical companies. It has therefore become imperative for pharmaceutical companies to invest in computational biology. In 2011, the global computational biology market was valued to be USD 760.2 million and is expected to grow at a CAGR of 21.3% from 2012 to 2018.

Computational biology also helps to reduce extensive use of humans in trials and is therefore useful for pediatric trials, trials on pregnant women and orphan disease research. The drug discovery market accounts to be the largest market for computational biology as its use at this stage helps in reduction of drug failure in the subsequent phase i.e. development phase. Currently, there is a large market of contract service providers of computational biology; nonetheless multinational pharmaceutical companies are setting up their own computational biology centers to fasten the process of drug discovery and development. Governments across the globe are funding infrastructure and academic courses to improve and increase the number of computational biologists.

Large pharmaceutical companies such as Pfizer, Roche, Novartis, and Sanofi are now exploring this market to have better outcomes of clinical trials. The drugs which have failed in the last stage of clinical trials are also being studied using computational biology to understand and apply its use for other disease indications. Though North America remains the largest market in the world, Asian countries namely India and China are witnessing fast growth and are predicted to emerge as dominating markets in the near future. The major players of this market are Schrödinger, Accelrys, Compugen, Entelos, Rhenovia Pharma and others.


Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Computational Biology Market Dynamics

Chapter 4 Global Computational Biology Market, by Applications

Chapter 5 Global Computational Biology Market, by Tools

Chapter 6 Global Computational Biology Market, by Services

Chapter 7 Global Computational Biology Market, by Geography

Chapter 8 Market Share Analysis

Chapter 9 Recommendations

Chapter 10 Company Profiles


Companies Mentioned:

  • Accelrys
  • Certara
  • Chemical Computing Group Inc.
  • Compugen, Ltd
  • Entelos
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc
  • Nimbus Discovery LLC
  • Rhenovia Pharma SAS
  • Schrodinger
  • Simulation Plus, Inc


For more information visit http://www.researchandmarkets.com/research/x7rj4s/computational


Media Contact: Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.